secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001193125-22-146929
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Moderna CFO Jorge Gomez departs amid Dentsply Sirona investigation; David Meline returns as CFO
--------------------------------------------------------------------------------

- Jorge Gomez terminated as CFO effective May 10, 2022, after former employer Dentsply Sirona disclosed an internal investigation.
- David Meline, previously CFO from June 2020 to July 2021, resumes role effective May 11, 2022.
- Gomez receives 12 months' salary ($700,000) and COBRA coverage; forfeits signing bonus, relocation, bonus, and new hire equity.
- Meline retains annual salary of $700,000, 90% bonus target, and full vesting of 2022 equity awards previously set to forfeit on retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/0001193125-22-146929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/d315485d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-146929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer